Investigation of p53, c-erbB-2, PCNA immunoreactivity, DNA content, AgNOR and apoptosis in bladder carcinoma as prognostic parameters

被引:13
作者
Koyuncuoglu, M [1 ]
Kargi, A
Cingöz, S
Kirkali, Z
机构
[1] Dokuz Eylul Univ, Dept Pathol, Sch Med, TR-35340 Izmir, Turkey
[2] Dokuz Eylul Univ, Dept Pathol, Dept Urol, TR-35340 Izmir, Turkey
关键词
bladder carcinoma; p53; c-erbB-2; PCNA; DNA; apoptosis; AgNOR; mitoses;
D O I
10.1016/S0304-3835(97)00532-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The association between known prognostic variables such as TNM stage, histological grade and mutant p53 tumor suppressor gene product, c-erbB-2 oncoprotein, DNA ploidy and cell kinetic data, including mitoses, PCNA expression, AgNOR scores and apoptosis, was investigated in 29 transitional cell carcinoma (TCC) cases. A positive correlation between the histologic grade and all the studied parameters, except for c-erbB-2 expression, and a positive correlation between the stage and histological grade, DNA ploidy, mitoses, apoptosis and p53 expression were found. The results of this study are in accordance with some of the previous studies, except for apoptosis which had been studied for the first time in TCCs. Although we found a statistically significant correlation between the apoptosis and both tumor stage and histological grade, the predictive value of apoptosis as an independent prognostic factor remains to be established in a larger series. (C) 1998 Elsevier Science Ireland Ltd.
引用
收藏
页码:143 / 148
页数:6
相关论文
共 22 条
[1]   PROGNOSTIC INDEXES IN TRANSITIONAL CELL-CARCINOMA OF THE BLADDER [J].
ABEL, PD .
BRITISH JOURNAL OF UROLOGY, 1988, 62 (02) :103-109
[2]   FREQUENCY OF APOPTOTIC BODIES POSITIVELY CORRELATES WITH GLEASON GRADE IN PROSTATE-CANCER [J].
AIHARA, M ;
TRUONG, LD ;
DUNN, JK ;
WHEELER, TM ;
SCARDINO, PT ;
THOMPSON, TC .
HUMAN PATHOLOGY, 1994, 25 (08) :797-801
[3]  
[Anonymous], 1973, HIST TYP UR BLADD TU
[4]  
Brierley JD., 2017, TNM Classification of Malignant Tumours, V8
[5]  
BRIGGS NC, 1992, CANCER-AM CANCER SOC, V69, P1445, DOI 10.1002/1097-0142(19920315)69:6<1445::AID-CNCR2820690623>3.0.CO
[6]  
2-S
[7]  
HOCKENBERY D, 1995, AM J PATHOL, V146, P16
[8]  
KERR JFR, 1994, CANCER-AM CANCER SOC, V73, P2013, DOI 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO
[9]  
2-J
[10]  
LEONCINI L, 1993, AM J PATHOL, V142, P755